纤维细胞激活蛋白-α放射性药物的发展:最近的进展和前景

Ziyue Yu1, Zeng Jiang1, Xuebo Cheng1

  • 1Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing, 100069, China.

概括

纤维细胞激活蛋白-α (FAP) 放射性药物在癌症成像和治疗方面表现有前途. 本综述涵盖了FAP向放射性连体的最新进展,它们的临床前和临床潜力以及未来的发展方向.